Industry Focus

Acadia Pharmaceuticals' dementia-related psychosis trial offers new hope to patients diagnosed with Alzheimer's disease.  Also, results from a lung cancer trial just strengthened Eli Lilly's leadership in precision medicine.

Stocks: ACAD, LLY

Direct download: IF_healthcare_09112019.mp3
Category:Podcast -- posted at: 4:01pm EST